Zynex Ret. on assets
What is the Ret. on assets of Zynex?
The Ret. on assets of Zynex, Inc. is 14.78%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on SSE compared to Zynex
What does Zynex do?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Companies with ret. on assets similar to Zynex
- Nemetschek SE has Ret. on assets of 14.77%
- Epiroc AB has Ret. on assets of 14.77%
- Epiroc AB (publ) has Ret. on assets of 14.77%
- Atlas Copco AB has Ret. on assets of 14.78%
- Navios Maritime Partners L.P has Ret. on assets of 14.78%
- Kewaunee Scientific has Ret. on assets of 14.78%
- Zynex has Ret. on assets of 14.78%
- Tapinator has Ret. on assets of 14.79%
- Oriental Culture LTD has Ret. on assets of 14.80%
- Consun Pharmaceutical has Ret. on assets of 14.80%
- Zynex has Ret. on assets of 14.80%
- Zynex has Ret. on assets of 14.80%
- Zynex has Ret. on assets of 14.80%